These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 11477143

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Epstein Barr viral load monitoring by quantitative PCR in renal transplant patients.
    Merlino C, Cavallo R, Bergallo M, Giacchino F, Bollero C, Negro Ponzi A, Cavallo G.
    New Microbiol; 2003 Apr; 26(2):141-9. PubMed ID: 12737195
    [Abstract] [Full Text] [Related]

  • 23. Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma.
    Araujo I, Foss HD, Hummel M, Anagnostopoulos I, Barbosa HS, Bittencourt A, Stein H.
    J Pathol; 1999 Feb; 187(3):326-30. PubMed ID: 10398087
    [Abstract] [Full Text] [Related]

  • 24. Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients.
    Colombini E, Guzzo I, Morolli F, Longo G, Russo C, Lombardi A, Merli P, Barzon L, Murer L, Piga S, Ciofi Degli Atti ML, Locatelli F, Dello Strologo L.
    Pediatr Nephrol; 2017 Aug; 32(8):1433-1442. PubMed ID: 28280938
    [Abstract] [Full Text] [Related]

  • 25. Duplex realtime PCR method for Epstein-Barr virus and human DNA quantification: its application for post-transplant lymphoproliferative disorders detection.
    Fellner MD, Durand K, Rodriguez M, Irazu L, Alonio V, Picconi MA.
    Braz J Infect Dis; 2014 Aug; 18(3):271-80. PubMed ID: 24389276
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Sustained Epstein-Barr virus detection in paediatric liver transplantation. Insights into the occurrence of late PTLD.
    D'Antiga L, Del Rizzo M, Mengoli C, Cillo U, Guariso G, Zancan L.
    Liver Transpl; 2007 Mar; 13(3):343-8. PubMed ID: 17154402
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [Abstract] [Full Text] [Related]

  • 30. Lytic and latent EBV gene expression in transplant recipients with and without post-transplant lymphoproliferative disorder.
    Kroll J, Li S, Levi M, Weinberg A.
    J Clin Virol; 2011 Nov; 52(3):231-5. PubMed ID: 21900040
    [Abstract] [Full Text] [Related]

  • 31. Changes in tonsils and adenoids in children with posttransplant lymphoproliferative disorder: report of three cases with early involvement of Waldeyer's ring.
    Lones MA, Mishalani S, Shintaku IP, Weiss LM, Nichols WS, Said JW.
    Hum Pathol; 1995 May; 26(5):525-30. PubMed ID: 7750936
    [Abstract] [Full Text] [Related]

  • 32. Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients.
    Zangwill SD, Hsu DT, Kichuk MR, Garvin JH, Stolar CJ, Haddad J, Stylianos S, Michler RE, Chadburn A, Knowles DM, Addonizio LJ.
    J Heart Lung Transplant; 1998 Dec; 17(12):1161-6. PubMed ID: 9883755
    [Abstract] [Full Text] [Related]

  • 33. Epstein-Barr virus gene expression and latent membrane protein 1 gene polymorphism in pediatric liver transplant recipients.
    Kasztelewicz B, Jankowska I, Pawłowska J, Teisseyre J, Dzierżanowska-Fangrat K.
    J Med Virol; 2011 Dec; 83(12):2182-90. PubMed ID: 22012727
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Prospective Epstein-Barr virus-related post-transplant lymphoproliferative disorder prevention program in pediatric allogeneic hematopoietic stem cell transplant: virological monitoring and first-line treatment.
    Chiereghin A, Prete A, Belotti T, Gibertoni D, Piccirilli G, Gabrielli L, Pession A, Lazzarotto T.
    Transpl Infect Dis; 2016 Feb; 18(1):44-54. PubMed ID: 26574232
    [Abstract] [Full Text] [Related]

  • 38. In situ hybridization for Epstein-Barr virus NotI repeats in posttransplant lymphoproliferative disorder.
    Montone KT, Friedman H, Hodinka RL, Hicks DG, Kant JA, Tomaszewski JE.
    Mod Pathol; 1992 May; 5(3):292-302. PubMed ID: 1323104
    [Abstract] [Full Text] [Related]

  • 39. Post-transplant lymphoproliferative disease in tonsils of children with liver transplantation.
    De Diego JI, Prim MP, Hardisson D, Verdaguer JM, Jara P.
    Int J Pediatr Otorhinolaryngol; 2001 Apr 27; 58(2):113-8. PubMed ID: 11278019
    [Abstract] [Full Text] [Related]

  • 40. Persistent Epstein-Barr virus infection: unrestricted latent and lytic viral gene expression in healthy immunosuppressed transplant recipients.
    Hopwood PA, Brooks L, Parratt R, Hunt BJ, Bokhari M, Thomas JA, Yacoub M, Crawford DH.
    Transplantation; 2002 Jul 27; 74(2):194-202. PubMed ID: 12151731
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.